Follow Us

header ads
header ads

U.S. Complex & Chronic Condition Management Market Size, Growth Analysis | Forecasts to 2030

As per the report, the U.S. complex & chronic condition management market size was US$ 3.2 billion in 2020. It is projected to grow US$ 8.7 billion by 2027 at a CAGR of 18% in the forecast period.

U.S. Complex and Chronic Condition Management Market Size 2020 to 2030

Chronic condition means patients living with the chronic diseases for years and the affected cells progress over time. The chronic diseases are the major revenue contributors to the healthcare industry. Complex & chronic condition management is a program that helps the patients and the healthcare professionals to improve the healthcare services and improve the patient’s quality of life. The chronic condition management services provide support to the patients from different medical services. The proliferation of digital technologies has encouraged the development of the telehealth industry. The rapid adoption of the telehealth services among both the healthcare professionals and consumers is the primary driver of the US complex & chronic condition management market.

Download the FREE Sample Report (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1455

Market Overview

A recent study by Precedence Research on the U.S. complex & chronic condition management market offers a forecast for 2021 and 2027. The study analyzes crucial trends that are currently determining the growth of the U.S. complex & chronic condition management market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of U.S. complex & chronic condition management. The study also provides the dynamics that are responsible for influencing the future status of this market over the forecast period.

A detailed assessment of the U.S. complex & chronic condition management market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the U.S. complex & chronic condition management market along with their product portfolio enhances the reliability of this comprehensive research study.

Highlights of the Report:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Key Points

  • Primary Research
  • Secondary Research
  • Market Size Estimation
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Challenges
  • Macroeconomic Indicators
  • Technology Trends and Assessment
  • Market Factor Analysis
  • Porter’s Five Forces Analysis
  • Bargaining Power Of Suppliers
  • Bargaining Power Of Buyers
  • Threat Of New Entrants
  • Threat Of Substitutes
  • Intensity Of Rivalry
  • Value Chain Analysis
  • Investment Feasibility Analysis
  • Pricing Analysis

Research Methodology

Secondary Research

It involves company databases such as Hoover's: This assists us recognize financial information, the structure of the market participants and industry's competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Industry participants involved in this research study include:

  • CEOs, VPs, market intelligence managers
  • Procuring and national sales managers technical personnel, distributors and resellers
  • Research analysts and key opinion leaders from various domains

Competition Landscape

In the final section of the report on the global U.S. complex & chronic condition management market, a 'dashboard view' of the companies has been provided to compare the current market scenario and the contribution of companies to the global U.S. complex & chronic condition management market. Moreover, the report is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to segments of the global market. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on an in-depth assessment of their capabilities and success in the U.S. complex & chronic condition management marketplace.

Some of the prominent players in the global U.S. complex & chronic condition management market include:

  • AllScripts
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Pegasystems, Inc.
  • Cognizant TriZetto Software Group Inc.
  • IBM Corporation
  • ScienceSoft USA
  • MINES & Associates, Inc.
  • Healthcare at Home
  • Mediware Information Systems

Market Segmentation

Segments of the global U.S. complex & chronic condition management market have been analyzed in terms of their market share to understand an individual segment’s relative contribution to market growth. This detailed level of information is important for identifying key trends in the global U.S. complex & chronic condition management market.

Market Segments as below:

By Disease Type

  • Cardiovascular Diseases
  • Oncology
  • Musculoskeletal
  • Women’s Health/Fertility/Maternity
  • Chronic Obstructive Pulmonary Disease
  • Others

By Service

  • Consulting Service
  • Implementation Service
  • Education Service
  • Others

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Complex & Chronic Condition Management Market 

5.1. COVID-19 Landscape: Complex & Chronic Condition Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Complex & Chronic Condition Management Market, By Disease

8.1. Complex & Chronic Condition Management Market, by Disease Type, 2021-2027

8.1.1. Cardiovascular Diseases

8.1.1.1. Market Revenue and Forecast (2017-2027)

8.1.2. Oncology

8.1.2.1. Market Revenue and Forecast (2017-2027)

8.1.3. Musculoskeletal

8.1.3.1. Market Revenue and Forecast (2017-2027)

8.1.4. Women’s Health/Fertility/Maternity

8.1.4.1. Market Revenue and Forecast (2017-2027)

8.1.5. Chronic Obstructive Pulmonary Disease

8.1.5.1. Market Revenue and Forecast (2017-2027)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2027)

Chapter 9. U.S. Complex & Chronic Condition Management Market, By Service

9.1. Complex & Chronic Condition Management Market, by Service, 2021-2027

9.1.1. Consulting Service

9.1.1.1. Market Revenue and Forecast (2017-2027)

9.1.2. Implementation Service

9.1.2.1. Market Revenue and Forecast (2017-2027)

9.1.3. Education Service

9.1.3.1. Market Revenue and Forecast (2017-2027)

9.1.3.2.

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2027)

Chapter 10. U.S. Complex & Chronic Condition Management Market, U.S. Estimates and Trend Forecast

10.1. U. S.

10.1.1. Market Revenue and Forecast, by Disease (2017-2027)

10.1.2. Market Revenue and Forecast, by Service (2017-2027)

Chapter 11. Company Profiles

11.1. AllScripts

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Siemens Healthineers

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Koninklijke Philips N.V.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Pegasystems, Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Cognizant TriZetto Software Group Inc.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. IBM Corporation

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. ScienceSoft USA

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. MINES & Associates, Inc.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Healthcare at Home

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Mediware Information Systems

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Why Buy this Report?

The purpose of Precedence Research's U.S. complex & chronic condition management market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1455

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Post a Comment

0 Comments